NOTICE OF BID SOLICITATION: 26DPP01283 - T3165 - NALOXONE, 4MG NASAL SPRAY, FDA-APPROVED, FOR THE NEW JERSEY DEPARTMENT OF HUMAN SERVICES' NALOXONE DIRECT PROGRAM

NOTICE OF BID SOLICITATION
NOTICE IS HEREBY GIVEN THAT QUOTES WILL BE RECEIVED BY THE PROPOSAL REVIEW UNIT,
ELECTRONICALLY THROUGH NJSTART (WWW.NJSTART.GOV), UNTIL 2:00 P.M. ON TUESDAY,
OCTOBER 27, 2026, FOR THE FOLLOWING BID SOLICITATION:
26DPP01283 - T3165 - NALOXONE, 4MG NASAL SPRAY, FDA-APPROVED, FOR THE NEW JERSEY
DEPARTMENT OF HUMAN SERVICES' NALOXONE DIRECT PROGRAM
QUOTES WILL BE PUBLICLY OPENED AND ANNOUNCED BY TELEPHONE CONFERENCE (DIAL-IN
PHONE NUMBER: 888-204-5984 / ACCESS CODE: 2602305).
INFORMATION ABOUT NJSTART AND THE BID SOLICITATION DOCUMENTS ARE AVAILABLE AT:
WWW.NJSTART.GOV.
STATE OF NEW JERSEY
DEPARTMENT OF TREASURY
DIVISION OF PURCHASE AND PROPERTY